157 related articles for article (PubMed ID: 28458903)
1. Using kisspeptin to assess GnRH function in an unusual case of primary amenorrhoea.
Vimalesvaran S; Narayanaswamy S; Yang L; Prague JK; Buckley A; Miras AD; Franks S; Meeran K; Dhillo WS
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28458903
[TBL] [Abstract][Full Text] [Related]
2. A practical guide to the diagnosis and management of amenorrhoea.
Crosignani PG; Vegetti W
Drugs; 1996 Nov; 52(5):671-81. PubMed ID: 9118817
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS).
Phylactou M; Clarke SA; Patel B; Baggaley C; Jayasena CN; Kelsey TW; Comninos AN; Dhillo WS; Abbara A
Clin Endocrinol (Oxf); 2021 Aug; 95(2):239-252. PubMed ID: 33354766
[TBL] [Abstract][Full Text] [Related]
4. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A
Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
[TBL] [Abstract][Full Text] [Related]
5. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
[TBL] [Abstract][Full Text] [Related]
6. Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome.
Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
Hum Reprod; 2020 Jun; 35(6):1421-1431. PubMed ID: 32510130
[TBL] [Abstract][Full Text] [Related]
7. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
[TBL] [Abstract][Full Text] [Related]
8. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE
J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454
[TBL] [Abstract][Full Text] [Related]
9. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
Ruchhoft EA; Elkind-Hirsch KE; Malinak R
Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
[TBL] [Abstract][Full Text] [Related]
10. The kisspeptin-GnRH pathway in human reproductive health and disease.
Skorupskaite K; George JT; Anderson RA
Hum Reprod Update; 2014; 20(4):485-500. PubMed ID: 24615662
[TBL] [Abstract][Full Text] [Related]
11. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome (PCOS) and kisspeptin - A Sri Lankan study.
Umayal B; Jayakody SN; Chandrasekharan NV; Wijesundera WS; Wijeyaratne CN
J Postgrad Med; 2019; 65(1):18-23. PubMed ID: 30004037
[TBL] [Abstract][Full Text] [Related]
13. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
14. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
15. Crocetin attenuates DHT-induced polycystic ovary syndrome in mice via revising kisspeptin neurons.
Hu Q; Jin J; Zhou H; Yu D; Qian W; Zhong Y; Zhang J; Tang C; Liu P; Zhou Y; Wang X; Sheng L
Biomed Pharmacother; 2018 Nov; 107():1363-1369. PubMed ID: 30257351
[TBL] [Abstract][Full Text] [Related]
16. Investigating the potential of clinical and biochemical markers to differentiate between functional hypothalamic amenorrhoea and polycystic ovarian syndrome: A retrospective observational study.
Abou Sherif S; Newman R; Haboosh S; Al-Sharefi A; Papanikolaou N; Dimakopoulou A; Webber LJ; Abbara A; Franks S; Dhillo WS; Jayasena CN
Clin Endocrinol (Oxf); 2021 Oct; 95(4):618-627. PubMed ID: 34323305
[TBL] [Abstract][Full Text] [Related]
17. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
[TBL] [Abstract][Full Text] [Related]
18. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
Bradbury RA; Lee P; Smith HC
Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
[TBL] [Abstract][Full Text] [Related]
19. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.
Fulghesu AM; Angioni S; Belosi C; Apa R; Selvaggi L; Ciampelli M; Iuculano A; Melis GB; Lanzone A
Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963
[TBL] [Abstract][Full Text] [Related]
20. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.
Arentz S; Abbott JA; Smith CA; Bensoussan A
BMC Complement Altern Med; 2014 Dec; 14():511. PubMed ID: 25524718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
